Lifitegrast Cas:1025967-78-5

We are Lifitegrast CAS:1025967-78-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description

Product Name: Lifitegrast CAS NO: 1025967-78-5

 

Synonyms:

L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-;

N-{[2-(1-Benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl}-3-(methylsulfonyl)-L-phenylalanine;

Lifitegrast;

N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine;

Lifitegrast(SAR 1118);

 

Chemical & Physical Properties

Appearance : white to off-white solid.

Assay : ≥99.0%

 

Lifitegrast is an antagonist of leukocyte functional antigen 1, which is used to treat dry eye. Lifetegras can bind to leukocyte functional antigen-1 (LFA-1) and prevent the binding of LFA-1 to its homologous ligand intercellular adhesion molecule-1 (ICAM-1). The overexpression of ICAM-1 in cornea and conjunctiva of patients with dry eye disease. The combination of lfachemic Book-1 and ICAM-1 promotes the formation of immune synapses, which leads to the activation of T cells and their migration to target tissues. In vitro studies showed that lifegrant could inhibit the adhesion of T cells to ICAM-1 and the secretion of inflammatory cytokines in human peripheral blood monocytes. The exact mechanism of lifegras in the treatment of dry eye remains unclear.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

 

Related Products:α-Acetyl-benzyliden-amino-oxacetamid manufacturer | tert-butyl-(8-chloro-1H-benzo[e][1,4]diazepin-5-yl)-amine supplier | 2-hydroxymethyl-3,4-dimethylphenol producer.